Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers. The organism carried the vanA resistance gene, which may have come from the vancomycin-resistant Enterococcus faecalis that was also isolated from the patient, who had received vancomycin for several weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing rates of oxacillin-resistant S aureus or MRSA isolates in both hospital and community settings and the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“and is especially prevalent in North America.6,138,139”
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Diagnostic molecular microbiology : principles and applications
Persing, D. H. (1993) · ASM Press eBooks · Cited by 1,311
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Self-citation(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus
Bannerman, T. L., Hancock, G. A., Tenover, F. C., & Miller, J. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.551-555.1995 · Cited by 550
Self-citationCharacterization of glycopeptide-resistant enterococci from U.S. hospitals
Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M., & Tenover, F. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2311 · Cited by 395
Self-citationApplication of pulsed-field gel electrophoresis to molecular epidemiology
Maslow, J. N. (1993) · Medical Entomology and Zoology · Cited by 382
Research works printed but not linked: 7
- 1997, MMWR Morb Mortal Wkly Rep, 46, 624
- 2000, MMWR Morb Mortal Wkly Rep, 48, 1165
- 2002, MMWR Morb Mortal Wkly Rep, 51, 565
- Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:264-82.
- 2001, MMWR Morb Mortal Wkly Rep, 50, 1
- 1995, MMWR Morb Mortal Wkly Rep, 44, 1
- 1997, MMWR Morb Mortal Wkly Rep, 46, 626
Cited by
Items 801–900 of 1,000
Infecciones de piel y partes blandas por grampositivos multirresistentes
Pigrau, C., & Barberán, J. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13123563 · Cited by 6
Amman, V. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.1611 · Cited by 6
Zarakolu, P., Metan, G., Altun, B., Hasçelik, G., & Ünal, S. (2009) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-0803-43 · Cited by 6
Fosheim, G. E., Carey, R. B., & Limbago, B. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02556-06 · Cited by 6
“Vancomycin continues to be an important antimicrobial agent for the treatment of methicillin-resistant Staphylococcus aureus infections and for empirical therapy of staphylococcal infections in areas where methicillin-resistant S. aureus prevalence is high ( 3 , 8). The widespread use of vancomycin has led to the emer…”
BackgroundNagy, G., Várvölgyi, C., Balogh, Z., Orosi, P., & Paragh, G. (2012) · Orvosi Hetilap · doi:10.1556/oh.2013.29514 · Cited by 6
Coagulase-Negative Staphylococci
Rohde, H., Horstkotte, M. A., Mack, D., & Knobloch, J. K. ‐. (2005) · CRC Press eBooks · doi:10.1201/9781420028232.ch7 · Cited by 12
An Obituary for the Case Report in Journal of Clinical Microbiology
McAdam, A. J. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01525-15 · Cited by 6
“For example, vancomycin-resistant staphylococci were first described in case reports (2, 3).”
BackgroundEdmond, M. B. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/503479 · Cited by 6
Enterococcus resistentes a glucopéptidos en Europa: un problema hospitalario creciente
Francia, M. V. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13078821 · Cited by 6
Glycopeptides and Bacterial Cell Walls
Santos‐Beneit, F., Martı́n, J. F., & Barreiro, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-40444-3_11 · Cited by 5
“The first cases of fully ‘vancomycin-resistant MRSA’ strains (VRSA) were reported in 2002 and, worryingly, there have been an increasing number of cases in the subsequent years (Chang et al. 2003; Alzolibani et al. 2012).”
BackgroundPharmacokinetics and Elimination Efficiency of Linezolid during Dialysis
Hiraki, Y., Tsuji, Y., Misumi, N., Hiraike, M., Matsumoto, K., Morita, K., Kamimura, H., & Karube, Y. (2013) · Renal Failure · doi:10.3109/0886022x.2012.761085 · Cited by 5
Winston, L. G., Deck, D. H., & Bolger, A. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50085-8 · Cited by 7
Raška, F., Lipový, B., Kobzová, Š., Vacek, L., Jarošová, R., Kleknerová, D. P., Matiašková, K., Makovický, P., Vícenová, M., Jeklová, E., et al. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12495 · Cited by 6
Mahafzah, A. M., Abu-Khader, I. B., & Bakri, F. G. (2010) · Jordan Medical Journal · Cited by 5
Brown, J. E., Brown, K., & Forrest, A. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.08.011 · Cited by 5
Faghri, J., Shahbazzadeh, D., Bagheri, K. P., Moghim, S., Safaei, H. G., Esfahani, B. N., Fazeli, H., Yazdani, R., & Hamid, M. (2012) · Europe PMC (PubMed Central) · Cited by 5
Emergence Of Vancomycin-Resistant Staphylococcus Aureus (VRSA)
Ng, S. T., Lim, C. Y., Tan, C. S., Karim, A. A., Haron, H., Ahmad, N. S., & Murugaiyah, V. (2011) · Cited by 8
Bera, D., Pal, K., Bardhan, S., Roy, S., Parvin, R., Karmakar, P., Nandy, P. S., & Das, S. (2019) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6254/ab5104 · Cited by 5
Doan, G., Doğanlı, G. A., Gursoy, Y., & Mercan, N. (2013) · InTech eBooks · doi:10.5772/55457 · Cited by 5
“To identify the resistance of staphylococcus’s against methycillin antibiotic, those methods as of disc diffusion, tube dilution or microdilution, agar scanning, agar dilution, automatise susceptibility tests, DNA hybridisation technics and polimeraze chain reaction have been used [7,8,9].”
MethodCuring plasmid-mediated vancomycin resistance in Staphylococcus aureus using herbal naphthoquinones
Jahagirdar, S., Patwardhan, R. B., & Dhakephalkar, P. K. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.04.021 · Cited by 6
Antimicrobial Drug Efflux Pumps in Staphylococcus aureus
Sapula, S. A., & Brown, M. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_7 · Cited by 9
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
Gern, B. H., Greninger, A. L., Weissman, S. J., Stapp, J. R., Tao, Y., & Qin, X. G. (2018) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-018-0257-x · Cited by 5
Resistencia de cepas de Staphylococcus aureus aislados en ambientes nosocomiales
Pazmiño, G. I. V., Tacuri, C. F. A., Bravo, P. P. O., & Tejedor, J. G. O. (2022) · Revista Vive · doi:10.33996/revistavive.v5i13.127 · Cited by 5
Veer, P. B., Chande, C. A., Chavan, S., Wabale, V., Chopdekar, K., Bade, J., & Joshi, A. (2010) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.71810 · Cited by 5
Tenover, F. C., & Rasheed, J. K. (2011) · Molecular Microbiology · doi:10.1128/9781555816834.ch32 · Cited by 6
Self-citationAntimicrobial resistance: is it really that bad?
Dowell, S. F. (2004) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2004.01.013 · Cited by 5
Dombrádi, Z., Bihari, Z., Horváth, K., & Szabó, J. (2010) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.57.2010.3.1 · Cited by 5
Invasive Staphylococcus aureus infections in diabetes mellitus
Hakeem, L. M., Laing, R. B. S., Tonna, I., Douglas, J. G., & Mackenzie, A. R. (2013) · The British Journal of Diabetes · doi:10.1177/1474651413500830 · Cited by 6
Prevalence of Vancomycin Resistant Enterococci in Hilla City, Iraq
Chabuck, Z. A. G., & Al-Charrakh, A. H. (2011) · Medical Journal of Babylon · Cited by 5
Staphylococcus aureus: resistance pattern and risk factors
Jafarzadeh, S., Sohrab-Navi, Z., Asl, M. M. B., Naghavi‐Behzad, M., Barband, S., Akhi, M. T., Alizadeh, M., Saleh, P., Sadeghi, G., Asghari, B., et al. (2015) · Journal of Analytical Research in Clinical Medicine · doi:10.15171/jarcm.2015.007 · Cited by 5
Anti-Gram Positive Agents of Natural Product Origins
LEE, V. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00222-4 · Cited by 5
Hermsen, E. D., Ross, G. H., & Rotschafer, J. C. (2007) · Infectious disease and therapy · doi:10.3109/9781420017137.009 · Cited by 6
News in Antimicrobial Resistance: Documenting the Progress of Pathogens
McGeer, A. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502356 · Cited by 5
Antimicrobial resistance in bacterial infections in urban and rural Tanzania
Blomberg, B. (2007) · NVA (Nasjonalt vitenarkiv) · Cited by 8
Antimicrobial lipopeptides: Multifaceted designs to curb antimicrobial resistance
Mukherjee, S., Dey, R. K., Acharya, Y., & Haldar, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95388-7.00007-3 · Cited by 4
Yaseen, A. R., Suleman, M., Habib, M., Arshad, T., Fatima, M., Arif, A., & Rasool, H. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10550-1 · Cited by 4
L’Entérocoque résistant à la vancomycine (ERV)
Lesens, O. (2009) · Néphrologie & Thérapeutique · doi:10.1016/s1769-7255(09)74556-0 · Cited by 4
“[15] Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al.”
BackgroundChaudhary, M., & Payasi, A. (2013) · Journal of Pharmacy Research · doi:10.1016/j.jopr.2013.01.013 · Cited by 4
“The vanA gene which codes for an altered target suchthat thebindingofvancomycinto thetarget is significantly reduced and thus it cannot carry out its normal functionof inhibitingbacterial cellwall synthesis.(5)However, the first reported case of reduced vancomycin susceptibility in a clinical isolate of S.”
BackgroundAlekshun, M. N. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.1.93 · Cited by 4
Haritsa, K. B., Shashikala, N., Chavan, S. K. D., & Sangeetha, S. (2014) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2014/3857 · Cited by 4
Kumaresan, G., Gangwar, C., Mishra, A. K., Kumar, A., Kharche, S. D., Singh, N. P., & Pachoori, A. (2022) · Archives of Microbiology · doi:10.1007/s00203-021-02731-7 · Cited by 5
VRE detection: A new gold standard?
Dodgson, K. J. (2004) · Clinical Microbiology Newsletter · doi:10.1016/s0196-4399(04)90013-x · Cited by 4
Staphylococcus-aureus-Infektionen
Becker, K., & von Eiff, C. (2008) · Elsevier eBooks · doi:10.1016/b978-343721741-8.50030-1 · Cited by 4
La resistencia bacteriana: ¿estamos preparados para detectarla?
Crespo, M. D. P. (2011) · Infectio · Cited by 4
Soltani, R., Khalili, H., Rasoolinejad, M., Gholami, K., & Abdollahi, A. (2012) · Research in Pharmaceutical Sciences · Cited by 4
“Syn&Sort”: A Chip‐based Tool for Combinatorial Synthesis
Gebinoga, M., Groß, G. A., Albrecht, A., Lübeck, T., Henkel, T., Hoffmann, P., Klemm, U., Schlingloff, G., Frank, T., & Schober, A. (2006) · QSAR & Combinatorial Science · doi:10.1002/qsar.200640113 · Cited by 4
Shimomura, R., & Tsutsumi, Y. (2007) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2007.07.004 · Cited by 4
Conduite adoptée face à une épidémie à ERG (ERV) dans un établissement de santé
Hénard, S., Cao-Huu, T., Ayav, C., Chanet, P., Kessler, M., & Rabaud, C. (2009) · Néphrologie & Thérapeutique · doi:10.1016/s1769-7255(09)74557-2 · Cited by 4
Kim, S.-R., Cha, M.-H., Chung, D., & Shim, W. (2015) · Journal of Food Hygiene and Safety · doi:10.13103/jfhs.2015.30.1.51 · Cited by 4
Buchanan, D., Heiss-Dunlop, W., & Mathy, J. A. (2012) · Hand Surgery · doi:10.1142/s0218810412500244 · Cited by 4
Hemodialysis-Associated Infections
Arduino, M. J., Patel, P. R., Thompson, N. D., & Favero, M. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00023-6 · Cited by 4
Navarini, A., Martino, M. D. V., Sasagawa, S. M., Massaia, I. F. D. S., & Mimiça, M. J. (2015) · PubMed · Cited by 4
Heunis, T. D. J. (2012) · SUNScholar (Stellenbosch University) · Cited by 7
Immunotherapeutics for nosocomial infections
Patti, J. M. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.6.673 · Cited by 4
“aureus (VRSA) in patients from Michigan [15] and Pennsylvania [16] has served to further highlight the increasing predicament clinicians face in treating serious S.”
BackgroundMultidrug-resistant microorganisms
SHEFF, B. (2003) · Nursing · doi:10.1097/00152193-200311000-00047 · Cited by 4
E. faecalis acquires resistance to antimicrobials and insect immunity via common mechanismsPreprint
Wadhawan, A., da Silva, C. J. S., Nunes, C. D., Edwards, A. M., & Dionne, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.17.504265 · Cited by 4
Vancomycin minimum inhibitory concentrations and lethality in Staphylococcus aureus bacteremia
Sulla, F., Bussius, D. T., Acquesta, F., Navarini, A., Sasagawa, S. M., & Mimiça, M. J. (2015) · GERMS · doi:10.11599/germs.2015.1069 · Cited by 3
Iida, H., Maehira, H., Kaida, S., Takebayashi, K., Miyake, T., & Tani, M. (2023) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12739 · Cited by 4
Ullah, Z., Ahmad, R., Shafqat, A., Li, M., & Tong, Y. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108017 · Cited by 3
Lertcanawanichakul, M. (2014) · International Journal of Pharma and Bio Sciences · Cited by 3
Borah, D., Singh, V., Gogoi, B., Hazarika, M., & Rahman, A. (2016) · Research Journal of Microbiology · doi:10.3923/jm.2016.126.132 · Cited by 3
Cheng, A. V., & Wuest, W. M. (2020) · ACS in focus · doi:10.1021/acs.infocus.7e4006 · Cited by 3
Surgical Site Infections and Antimicrobial Prophylaxis
Talbot, T. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00317-9 · Cited by 3
Khan, S., Hou, B., Khan, M. N., Shafiq, M., Cai, L., Fang, W., Wang, Q., Bilal, H., & Zeng, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1549470 · Cited by 3
“MRSA resistance to vancomycin due to genetic acquisition (vanA/B), adaptive mutations Vancomycin-Intermediate S. aureus , or bio fi lm-mediated tolerance (Chang et al., 2003; Holmes et al., 2012; Alav et al., 2018).”
Antibiotic Activity of Streptomyces Isolates Collected From Soil of Kogi Central, Nigeria
Bello, K. E. (2013) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-0847884 · Cited by 3
VANCOMYCIN RESISTANT ENTEROCOCCI AT A TERTIARY CARE HOSPITAL IN NORTHERN INDIA
Kalyan, R., Singh, M., & Agarwal, J. (2013) · Cited by 3
Manzoor, M., Bali, N. K., Reshi, S., Jan, A., Kakru, D. K., Bhat, A., & Ahmad, J. (2016) · British Microbiology Research Journal · doi:10.9734/bmrj/2016/29246 · Cited by 3
“reservoirs of antibiotic resistant genes tend to transfer their resistance genes to the other bacteria, including methicillin-resistant Staphyloccocus aureus [18].”
BackgroundAmiri, E., & Anvari, M. (2018) · فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران · doi:10.29252/iau.28.1.74 · Cited by 3
STUDY OF VANCOMYCIN RESISTANCE AMONG STAPHYLOCOCCUS AUREUS
de Albuquerque, V. C., Flores, V. C. J., Zeron, R. M. C., Godoi, B. B., Filho, W. M. N. E., & dos Santos, B. A. (2019) · Amadeus International Multidisciplinary Journal · doi:10.14295/aimj.v3i6.58 · Cited by 3
Antibiotic Consideration in Transplant Recipients
Altshuler, J., Aitken, S. L., Maslow, M. J., Papadopoulos, J., & Safdar, A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_50 · Cited by 3
Ibezim, A., Onuku, R., Ottih, C., Ezeonu, I. M., Onoabedje, E. A., Ramanathan, K., & Nwodo, N. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2111359 · Cited by 4
“Even with controlled use, treatment options are constantly trimmed down because of the emergence and spread of new strains that show decreased susceptibility, or utter resistance, to these drugs (Appelbaum, 2006; Chang et al., 2003; Hiramatsu et al., 1997; Stryjewski & Corey, 2014).”
BackgroundKamei, K.-I. F., Okura, R., Kobayashi-Kirschvink, K. J., Yamaguchi, T., Katayama, Y., & Wakamoto, Y. (2026) · mBio · doi:10.1101/2024.05.12.593718 · Cited by 3
Antibiotic resistance and nosocomial infections
Lubelchek, R., & Weinstein, R. A. (2008) · Elsevier eBooks · doi:10.1016/b978-012370466-5.50014-5 · Cited by 3
Staphylococcus aureus and Related Staphylococci
Missiakas, D. M., & Schneewind, O. (2015) · CRC Press eBooks · doi:10.1201/b17871-28 · Cited by 5
Młynarczyk, A., Młynarczyk, G., & Łuczak, M. (2003) · PubMed · Cited by 3
Quality Assurance and Continuous Quality Improvement Programs for Vascular Access Care
Walters, B. A. J., Pennell, P., & Bosch, J. P. (2003) · KARGER eBooks · doi:10.1159/000074850 · Cited by 3
Politique de dépistage des BMR : quand et qui faut-il dépister ?
Birgand, G., & Lucet, J. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)72079-3 · Cited by 4
Antiproliferative and antibacterial activity evaluation of red microalgae Rhodosorus marinus
García-Galaz, A., Gutiérrez-Millán, L. E., Valdéz-Covarrubias, M. A., Acedo‐Félix, E., Burgos‐Hernández, A., López‐Torres, M. A., & Maria, G. B. Z. (2014) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2014.13943 · Cited by 3
“J. Biotechnol. populations while antiproliferatives are used in the control of cancer cells growth (Alexander and Hong, 2008; Chang et al., 2003; Granier et al., 2011).”
BackgroundMatyi, S. A., Ramaraj, T., Sundararajan, A., Lindquist, I. E., Devitt, N. P., Schilkey, F., Lamichhane-Khadka, R., Hoyt, P. R., Mudge, J., & Gustafson, J. E. (2014) · Genome Announcements · doi:10.1128/genomea.00688-14 · Cited by 3
Vancoplus Kinetic Study in Vancomycin Resistant Staphylococcus aureus
Chaudhary, M., & Payasi, A. (2015) · Cited by 3
In Vitro Assessment of Vancomycin Released from Bone Grafts
Melicherčík, P., Jahoda, D., BARTÁK, V., Klapková, E., Nyč, O., POKORNÝ, D., Landor, I., Sosna, A., & Judl, T. (2010) · Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca · doi:10.55095/achot2010/070 · Cited by 3
Bohlouli, P., Reza, N. M., Farajnia, S., Varshochi, M., Ghojazadeh, M., Mohammad, A. D., & Firouzeh, S. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
The Molecular Mechanics of Inflammatory Bone and Joint Disease Caused by Microbial Infection
Kavanagh, N., O’Brien, F. J., & Kerrigan, S. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811079-9.00008-2 · Cited by 3
The Risk of Vancomycin Resistant Enterococci Infections from Food Industry
Terkuran, M., Turhan, E. Ü., & Erginkaya, Z. (2019) · Springer eBooks · doi:10.1007/978-3-030-24903-8_18 · Cited by 3
(2013) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-0840913 · Cited by 3
HEALTH CARE–ASSOCIATED INFECTIONS
Huskins, W. C., & Goldmann, D. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50249-1 · Cited by 3
Mathematical and statistical modelling of infectious diseases in hospitals
McBryde, E. S. (2006) · ResearchOnline at James Cook University (James Cook University) · Cited by 4
Nosocomial Outbreak of Serratia marcescens in a Neonatal Intensive Care Unit
Muñoz, J. M., & Macías, A. E. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/503480 · Cited by 3
Plasmid Driven Evolution of Bacteria
Ridenhour, B. J., & Top, E. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800049-6.00237-7 · Cited by 3
Staphylococcus aureus as a foodborne pathogen
Hussain, M. (2022) · CABI Compendium · doi:10.1079/cabicompendium.59055 · Cited by 3
A dazzle of zebras: launch of ASM Case Reports
Burnham, C. D. (2024) · ASM Case Reports · doi:10.1128/asmcr.00002-24 · Cited by 3
Vancomicina. Un Vencedor Vencido
Betancourt, A. N., Rodríguez, C. M. M., Martínez, M. E. R., & González, Á. L. G. (2006) · MEDICRIT Revista de Medicina Crítica · doi:10.5413/mrmc.2006.36.79 · Cited by 2
Omer, H., Darweesh, O., Karim, G. F., Rashid, B., Ahmed, R., Seaton, A., Godman, B., & Kurdi, A. B. (2026) · JMIR Public Health and Surveillance · doi:10.2196/94436 · Cited by 2
Issues in the Identification and Susceptibility Testing of Staphylococci
Forbes, B. A. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch11 · Cited by 3
Bacterial Genotypic Drug Resistance Assays
Huletsky, A., & Bergeron, M. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_37 · Cited by 2
Novel Effective Small-Molecule Antibacterials against Enterococcus Strains
Ashraf, K., Yasrebi, K., Hertlein, T., Ohlsen, K., Lalk, M., & Hilgeroth, A. (2017) · Molecules · doi:10.3390/molecules22122193 · Cited by 2
“Importantly, such transferred resistances have also been observed in cases of vancomycin between Enterococcus and Staphylococcus species, and contribute to an intensification of critical resistance development [6,7].”
BackgroundLertcanawanichakul, M., & Chawawisit, K. (2020) · International Journal of Pharmaceutical Sciences and Developmental Research · doi:10.17352/ijpsdr.000028 · Cited by 2
“However, because of the development of new anti-staphylococcal antibiotics, several researches reported vancomycin failure [5-6].”
BackgroundChang, C., Lee, S., Lin, Y., Hsu, C., Cheng, C.-C., Teng, S.-H., Chen, M., Hsieh, P., Chang, Y., & Chiang-Ni, C. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.08.006 · Cited by 2
Boury, N. M., van den Bogaard, M., Wasendorf, C., Amon, J. D., Judson, S., Maroushek, S. R., & Peters, N. T. (2022) · Journal of Microbiology and Biology Education · doi:10.1128/jmbe.00125-22 · Cited by 2
Mechanisms of Microbial Resistance to Known Antibiotics
Kelechi, A. A., & Uchechukwu, E. E. (2015) · Science Journal of Public Health · doi:10.11648/j.sjph.s.2015030501.14 · Cited by 2
“Another example of an altered target mechanism includes substitution of amino acids in the quinolone-resistance determining region (QRDR) of DNA gyrase and topoisomerase IV resulting in less efficient binding of quinolone antibiotics [18].”
Background
Metadata
- Authors
- Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., Cardo, D., & Fridkin, S. K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Michigan Department of Health and Human Services (US)
- Wayne State University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1342-1347
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068037991
- Semantic Scholar
- f0afb59f819a65ada63076a36807f63502c4437d
- Cited by
- 1,095
- References
- 18
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 24 · 2023: 28 · 2022: 24 · 2021: 35 · 2020: 29 · 2019: 39 · 2018: 28 · 2017: 29 · 2016: 28 · 2015: 55 · 2014: 54 · 2013: 51 · 2012: 65
- FWCI
- 54.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- vancomycin-resistant Staphylococcus aureus, vanA gene, vancomycin resistance, diabetes mellitus, peripheral vascular disease, foot ulcer, vancomycin-resistant Enterococcus faecalis, antibiotic resistance transfer, catheter-related infection
- MeSH terms
- Adult, Catheterization, Debridement, Female, Renal Dialysis, Humans, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Contact Tracing, Diabetic Foot, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.